Literature DB >> 32887706

Psychosocial Moderators of the Impact of Diabetes Stigma: Results From the Second Diabetes MILES - Australia (MILES-2) Study.

Elizabeth Holmes-Truscott1,2, Adriana D Ventura3,2, Sharmala Thuraisingam3,2, Frans Pouwer3,4, Jane Speight3,2,4.   

Abstract

OBJECTIVE: To examine the association of diabetes stigma with psychological, behavioral, and HbA1c outcomes and to investigate moderation effects of self-esteem, self-efficacy, and/or social support. RESEARCH DESIGN AND METHODS: The national Second Diabetes MILES - Australia (MILES-2) survey included adults with type 1 diabetes (n = 959, 41% of whom were male, with mean ± SD age 44 ± 15 years), insulin-treated type 2 diabetes (n = 487, 60% male, age 61 ± 9 years), and non-insulin-treated type 2 diabetes (n = 642, 55% male, age 61 ± 10 years). (Un)adjusted linear regression analyses tested the association between diabetes stigma (Diabetes Stigma Assessment Scale [DSAS]) and psychological outcomes (depressive symptoms [eight-item version of the Patient Health Questionnaire (PHQ-8)], anxiety symptoms [Generalized Anxiety Disorder 7-item (GAD-7) questionnaire], and diabetes-specific distress [20-item Problem Areas In Diabetes (PAID) scale]), behavioral outcomes (healthy diet and physical activity [Summary of Diabetes Self-Care Activities (SDSCA)]), and self-reported HbA1c. Interaction effects tested whether associations varied by self-esteem (Rosenberg Self-Esteem Scale [RSES]), self-efficacy (Confidence in Diabetes Self-Care [CIDS] scale), or diabetes-specific social support (Diabetes Support Scale [DSS]).
RESULTS: Significant positive associations were observed between DSAS and PHQ-8, GAD-7, and PAID across diabetes type/treatment groups (all P < 0.001), whereby each SD increase in DSAS scores was associated with approximately one-half SD deterioration in emotional well-being. Associations between DSAS and SDSCA and HbA1c were nonmeaningful. Self-esteem moderated psychological outcomes among participants with type 1 and non-insulin-treated type 2 diabetes and diabetes distress among those with insulin-treated type 2 diabetes. Interaction effects were partially observed for social support but not for self-efficacy.
CONCLUSIONS: This study provides evidence of the association between diabetes stigma and depressive/anxiety symptoms and diabetes distress and for the moderating effects of self-esteem and social support among adults with type 1 and type 2 diabetes. Further research is needed to examine associations with objectively measured behavioral and clinical outcomes.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32887706     DOI: 10.2337/dc19-2447

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

1.  Relationship between perceived social stigma and diabetes self-care activities in Iranian participants with type 1 diabetes.

Authors:  Parisa Mahdilouy; Marzieh Ziaeirad
Journal:  J Diabetes Metab Disord       Date:  2021-09-08

2.  Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data.

Authors:  Asuka Kato; Yuko Fujimaki; Shin Fujimori; Akihiro Isogawa; Yukiko Onishi; Ryo Suzuki; Kohjiro Ueki; Toshimasa Yamauchi; Takashi Kadowaki; Hideki Hashimoto
Journal:  BMJ Open       Date:  2021-12-30       Impact factor: 2.692

3.  Psychometric properties of the Spanish version of the Type 2 Diabetes Stigma Assessment Scale (DSAS 2) in a Colombian population

Authors:  Victor Pedrero; Luz Marina Alonso; Jorge Manzi
Journal:  Biomedica       Date:  2022-05-01       Impact factor: 1.173

4.  Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 Diabetes.

Authors:  Ashby F Walker; Korey K Hood; Matthew J Gurka; Stephanie L Filipp; Claudia Anez-Zabala; Nicolas Cuttriss; Michael J Haller; Xanadu Roque; Diana Naranjo; Gina Aulisio; Ananta Addala; Jason Konopack; Sarah Westen; Katarina Yabut; Elvira Mercado; Sydney Look; Brian Fitzgerald; Jennifer Maizel; David M Maahs
Journal:  Diabetes Care       Date:  2021-05-17       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.